On behalf of the Foreign Affairs, Defence and Trade References Committee, I present additional information received by the committee on its inquiries into the impact of defence training activities and facilities on rural and regional communities and the use of the quinoline anti-malarial drugs mefloquine and tafenoquine in the Australian Defence Force.